If youre overweight but have normal insulin sensitivity and no significant metabolic dysfunction, you may be Tier 2
"Weight loss and changes in nutritional status, common consequences of GLP-1 receptor agonist therapy, are established risk factors for telogen effluvium, a common and typically transient form of non-scarring hair loss, providing a plausible biological mechanism for this association," write the researchers
For patients, tools such as continuous glucose monitoring (CGM) and other real-time physiological data, provide powerful insights into how their bodies respond, helping them engage more actively in their own care and adopt healthier habits
These include: Nausea Abdominal pain Diarrhea Vomiting Constipation These side effects are most frequent when starting the medication and when increasing the dose
The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes
With your healthcare providers clear instructions and training on using syringes, you can prevent mistakes and more effectively reach your weight-loss goals